The clinical guideline on Suspected cancer: recognition and referral (NG12) has been checked by NICE for the need for update.
Registered stakeholders for the guideline are invited to comment on the provisional decision via this website.
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.
Not eligible? Contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.
We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.
Note that the provisional review decision presented here does not constitute NICE's formal decision on this guideline. The decision is provisional and may change after consultation.
Consultation dates: from 9am on Thursday, 31 October 2019 to 5pm on Thursday, 14 November 2019.
Consultation documents:
How to submit your comments:
Please provide all responses to the review proposal document using the comments form (ensuring all relevant fields are completed, including your organisation’s full name) and forward this by email before 5pm on Thursday, 14 November 2019.
to the following email address:
NICE is unable to accept:
- Comments from non-registered organisations – if you wish your comments to be considered please register via the NICE website
- Comments received after the consultation deadline (5pm)
- Comments that are not on the correct form
- More than one response per stakeholder organisation
- Confidential information or other material that you would not wish to be made public
- Personal medical information about yourself or another person from which your or the person’s identity could be ascertained.
What will happen to your comments?
- Comments from registered stakeholders and nominated expert reviewers ONLY will be sent to the review team at the end of the consultation. These will inform the final decision made by the NICE Guidance Executive.
- No action will be taken upon receipt of personal comments, comments from non-registered organisations and late comments.
Anticipated review decision publication date: January 2020
Further information:
-
-
-
-
-
-
-
-
-
Recommendations equalities impact assessment form (PDF 97 KB)
-
-
-
-
-
-
-
-
-
-
-
-
Referral for suspected cancer: sixteenth GDG minutes - 1 and 2 September 2014 (PDF 90 KB)
-
Referral for suspected cancer: fifteenth GDG minutes - 16 and 17 July 2014 (PDF 91 KB)
-
Referral for suspected cancer: fourteenth GDG minutes - 3 and 4 June 2014 (PDF 178 KB)
-
Referral for suspected cancer: thirteenth GDG minutes - 22 and 23 April 2014 (PDF 18 KB)
-
Referral for suspected cancer: twelfth GDG minutes - 23 and 24 March 2014 (PDF 31 KB)
-
Referral for suspected cancer: eleventh GDG minutes - 27 and 28 January 2014 (PDF 95 KB)
-
Referral for suspected cancer: tenth GDG minutes - 25 and 26 November 2013 (PDF 97 KB)
-
Referral for suspected cancer: ninth GDG minutes - 3 and 4 October 2013 (PDF 94 KB)
-
Referral for suspected cancer: eighth GDG minutes - 4 September 2013 (PDF 96 KB)
-
Referral for suspected cancer: sixth GDG minutes - 23-24 July 2013 (PDF 77 KB)
-
Referral for suspected cancer: fifth GDG minutes - 5-6 March 2013 (PDF 95 KB)
-
Referral for suspected cancer: fourth GDG minutes - 12 Dec 2012 (PDF 94 KB)
-
Referral for suspected cancer: third GDG minutes - 17 Sept 2012 (PDF 91 KB)
-
Referral for suspected cancer: second GDG minutes - 24 July 2012 (PDF 94 KB)
-
Referral for suspected cancer: first GDG minutes - 19 and 20 June 2012 (PDF 109 KB)
-
Suspected cancer: scoping equalities impact assessment form (PDF 30 KB)
-
Suspected cancer: scope consultation table with responses (PDF 620 KB)
-
-
-
This page was last updated: